Skip to main content.

Alzheimer's Black Community

Picture of Darlene Donloe
The fourth and last in a series of articles on the impact of Alzheimer’s disease on the Black community in Los Angeles.
Picture of Darlene Donloe
Aducanumab is the first new drug approved to treat Alzheimer’s disease in nearly 20 years. But some in the medical community were stunned by the approval.
Picture of Darlene Donloe
“We are still trying to understand how it manifests and how it happens,” said Dr. Emnet Gammada, a clinical geriatric neuro-psychology fellow at the UCLA Semel Institute of Neuroscience and Human Behavior. “What surprises me is how much we know and how much we don’t know.”
Picture of Darlene Donloe
This is the second in a series of articles produced by Darlene Donloe, a 2021 California Fellow, on the impact of Alzheimer’s disease on the Black community in Los Angeles.

Announcements

Join us for a conversation on the latest COVID thread with Dr. Céline Gounder, a leading infectious disease expert, epidemiologist, medical analyst and host of the COVID podcast “Epidemic.” We'll discuss the emerging research, clarify what we know and don’t, and help attendees think through where the pandemic takes us from here. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth